Smoking Cessation in Cancer Patients 2019 - Research Project Grant

Smoking Cessation in Cancer Patients 2019 - Research Project Grant


Smoking is a leading cause of preventable mortality in Ireland resulting in approximately 5,950 deaths in 2018 (1), approximately half of which are cancer deaths. Continued smoking after a cancer diagnosis results in adverse health outcomes and increased mortality (2), and may be associated with poorer response to treatment, increased treatment-related toxicity, and poorer health-related quality of life (3). 

Conversely, research has also shown that smoking cessation after diagnosis can result in improvements in survival, treatment efficacy, and outcomes (2). This is recognised in the National Cancer Strategy (2017-2026) (4), which recommends that “smokers should be given appropriate smoking cessation supports as part of their treatment regime and care planning”. 

The Health Service Executive (HSE) currently offer a number of cessation programmes, from brief to intensive interventions, with the delivery varying from online to face-to-face. The HSE’s National Standard for Tobacco Cessation Support Programme (5) provides a framework for intensive behavioural intervention.

However, international evidence suggests that discussion of tobacco use and cessation services are not routinely offered to patients within healthcare services, despite recognition of its importance (6,7). Additionally, HSE cessation programmes are not disease- or time-specific and it is unknown how routinely or consistently cessation interventions are being offered to patients with cancer. When the service is offered, rates of uptake and attendance are unclear. 

Therefore, the aim of this award is to fund a focused scoping study regarding the provision of a hospital-based smoking cessation programme as part of routine clinical care for patients with cancer.


It is the intention of the Irish Cancer Society to provide funding for one grant in 2019, subject to grant proposals meeting the required standard as assessed by international peer review. The Smoking Cessation in Cancer Patients Grant will provide funding of up to €65,000 for a project of up to a maximum of 18 months duration.

How to apply

Eligible applicants can submit an application through the Irish Cancer Society Grant Tracker online system.

Deadline (extended)

Submission deadline extended: 3.00 pm 09 September 2019

Related documents

For more information on eligibility criteria, funding etc please read the Guidelines for Applicants.



1. Kavanagh, P., & Sheridan, A. (2018). The State of Tobacco Control in Ireland: HSE Tobacco Free Ireland Programme. Health Service Executive. 

2. US Department of Health and Human Services. (2014). The health consequences of smoking—50 years of progress: a report of the Surgeon General. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health.

3. World Health Organisation (WHO). (2018). Tobacco & Cancer Treatment Outcomes: WHO Tobacco Knowledge Summaries. World Health Organisation.

4. Department of Health. (2018). National Cancer Strategy 2017-2026. Retrieved from:

5. Health Service Executive (HSE). 2013. National Standard for Tobacco Cessation Support Programme. Retrieved from:

6. Cooley, et al. (2011). Patient‐reported receipt of and interest in smoking‐cessation interventions after a diagnosis of cancer. Cancer, 117(13), 2961-2969.

7. Warren, et al. (2013). Addressing tobacco use in patients with cancer: a survey of American Society of Clinical Oncology members. Journal of oncology practice, 9(5), 258-262.


Date Last Reviewed: 
Thursday, July 11, 2019